Glioblastoma–Neuroblastoma Cocultured Multicellular Spheroid Model for Evaluating Temozolomide Response
Year: 2026
Type: article
Abstract: Glioblastoma is the most lethal primary brain tumor, and its resistance to therapy is increasingly understood to arise not from tumor cells alone but also from their integration into the surrounding neural circuitry. However, no existing preclinical spheroid model isolates the direct effect of neuronal-lineage cells on glioblastoma's drug response within a rapid, scalable 3D system. We developed a heterotypic 3D coculture spheroid combining glioblastoma (U87-MG) with a neuronal-lineage surrogate population (SH-SY5Y) via the agarose liquid overlay method to directly understand this gap. Subsequently, growth, morphology, hypoxia, and temozolomide (TMZ) response over 14 days against glioblastoma only and neuroblastoma only spheroids were characterized. The coculture adopted a glioblastoma like compact, chemoresistant architecture yet, contrary to what this architecture alone would predict, it showed measurable chemosensitivity at every TMZ concentration tested, including 10 µM, a dose at which neither monoculture responded at all. This indicates that the neuronal-lineage surrogate population alters the overall TMZ response of the coculture spheroids. Drug-response data from glioblastoma only models may therefore not reflect true tumor behavior in the presence of neuronal-lineage cells, supporting the inclusion of neuronal-lineage surrogate components in preclinical glioblastoma drug screening.
Source: ChemBioChem
DOI: 10.1002/cbic.70606
Authors: Sivasubramanian Murugappan(Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Ajay Mali(Formal analysis, Software), Puja Sandbhor(Writing – original draft, Writing – review & editing), Nanasaheb Thorat(Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Irish Research Council
Award: G2115577451
OpenAlex ID: W4404261193
